Pfizer bought Global Blood Therapeutics Global Blood Therapeutics from 10/5/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Pfizer completed its acquisition of Global Blood Therapeutics for $5.4, or $68.5 per share.

Global Blood Therapeutics

Review

Source:

{source} pictogram

investors.pfizer.com

Vladimir Petenev

News editor

Write your comment first

News feed

VK launched a unified authorization service for businesses and developers

6/26/24 VKCO

Softline will create a platform for automation of business processes in the retail industry

6/26/24 SOFL

Rostelecom plans to buy a data center for 4,000 racks

6/26/24 RTKM

Shareholders of Sovcombank approved dividends for 2023

6/26/24 SVCB

Shareholders of Stavropolenergosbyt approved dividends for 2023

6/25/24 STSB

KASE asked Moscow Exchange to exit

6/25/24 MOEX

Shareholders of Diod approved dividends for 3 months 2024

6/25/24 DIOD

Shareholders of Renaissance Insurance approved dividends for 2023

6/25/24 RENI

Shareholders of Sollers approved dividends for 2023

6/25/24 SVAV

Delimobile will increase its fleet by 900 Chery cars

6/25/24 DELI